International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial
08 oct. 2018 08h30 HE
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...